黛力新治疗功能性消化不良临床分析  

Clinical Analysis of Curative Effects of Dailixin on Functinal Dyspepsia

作　　者：戴禄寿[1] 郭世春[1] 陈文柳[1] 

机构地区：[1]解放军第174医院,福建厦门361003

出　　处：《临床军医杂志》2007年第1期77-78,共2页Clinical Journal of Medical Officers

摘　　要：目的比较黛力新联合雷贝拉唑、贝络纳与雷贝拉唑,贝络纳治疗功能性消化不良近期疗效及半年复发情况。方法将90例经内镜等检查诊断为功能性消化不良的门诊患者,随机分为:治疗组50例和对照组40例,治疗组采用黛力新联合雷贝拉唑、贝络纳治疗;对照组采用雷贝拉唑、贝络纳治疗。结果治疗组及对照组治疗8周后症状改善,餐后饱胀不适及早饱、反复上腹疼痛,上腹烧灼总有效率及症状积分有效率分别为94.0%,83·3%,96.4%,88.5%和85.0%;73.5%,86.9%,81.5%。半年复发率分别为14.0%及25.0%,二组比较有效率差异显著(P<0.05)。结论黛力新与雷贝拉唑对功能性消化不良的近期及维持治疗均有良好疗效,无明显不良反应,但停药后复发率较高,需要维持治疗。Objective To compare the efficacy of dailixin plus leibeirazole with that of leibeirazole in the treatment of functional dyspepsia （ FD）, and their haft year relapse. Methods A total of 90 patients with （FD） diagnosised by endoscopy were divided into observing group （ n = 50 ） and control group （ n = 40） at random. The former group was administered with dailixin, lcibeirazole and mosapride, and the latter one with leibeirazole and mosapride. Their clinical symptoms were compared. Results The effective rate and haft-year relapse rate were respectively 94.0% and 14.0% for the observing group, while the counterparts of the control group were 85.0% and 25.0%. There were significant differences in the parameters between the two guoup （ P 〈 0. 05 ）. Conclusion It is safe and effective that dailixin plus leibeirazole is applied to the treatment of FD. Maintaining treament is required in many patients.

关 键 词：黛力新 雷贝拉唑 功能性消化不良 

分 类 号：R571[医药卫生—消化系统]